Vector Science & Therapeutics Files Provisional Patent for Novel Microneedle Catheter Platform for Intratumoral Drug Delivery
Platform Integrates Three Research Modalities Targeting the Electrical Properties of Tumor Biology in Pancreatic Cancer MEQUON, Wis., May 1, 2026 /PRNewswire/ -- (TSXV: PAIN) — Vector Science & Therapeutics (the "Company") today announced the filing of a provisional patent application...
Extrait seulement — cet éditeur protège son texte. Lisez le communiqué complet à la source.
Forfait Gratuit · Plus 29 $ CA ou Pro 99 $ CA/mois


